Hidradenitis suppurativa (HS) is a chronic inflammatory HS skin disease that most people have never heard of – yet it affects ...

Chaz Frazier experienced his first sign of hidradenitis suppurativa (HS) in the spring of 2018. He had a bump in his armpit that was so painful, he went to the emergency room. At the hospital, they ...

Incyte Corp (INCY) reports a robust start to 2026 with a 21% revenue increase and advances in its late-stage pipeline, despite challenges in diversifying beyond Jakafi.

HKeybio Tech., a global leader in non-human primate (NHP) experimental animal model research and development, today announced the official launch of the world's first NHP Hidradenitis Suppurativa (HS) ...

Children with hidradenitis suppurativa often receive antibiotics for about a year before switching to other therapies, a ...

Add a second biologic or JAK1 inhibitor to biologic monotherapyAvoid adding an IL-1 inhibitor, which could raise infection risk ...

Bimekizumab at different dosing intervals was associated with greater IHS4 improvements at week 48 than placebo in patients with HS.

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. New data show high levels of response at 54 weeks with ...

Christina Frazier is a wife to an HS Warrior and mom to two small children. Through her husband’s advocacy work, Christina has developed an interest in raising awareness of hidradenitis suppurativa ...

Incyte’s povorcitinib has scored a pair of phase 3 wins for a skin condition, although analysts noted the oral JAK inhibitor ...

Pursuant to the Buyout Agreement, Avalo has agreed to pay $2.25 million to the former AlmataBio securityholders for an option, exercisable within 90 days of the effective date, to pay an additional $5 ...

They were symptoms of hidradenitis suppurativa, a chronic inflammatory skin condition characterized by recurring abscesses, ...